Wealth Enhancement Advisory Services, LLC Mirum Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 16,685 shares of MIRM stock, worth $744,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,685
Previous 16,346
2.07%
Holding current value
$744,985
Previous $675,000
11.26%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$303 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$213 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$145 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$125 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...